David C. Hooper
1893–2025 年に発表
- 別表記
- DAVID C. HOOPER
- 128
- 論文数
- 29,335
- 被引用数
- 94
- h 指数
- 122
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Biochemistry, Genetics and Molecular Biology46.9%
- Medicine30.8%
- Immunology and Microbiology6.4%
- Environmental Science4.5%
- Agricultural and Biological Sciences3.8%
- Chemistry1.5%
- その他6.1%
トピック
- Antibiotic Resistance in Bacteria15.8%
- Antibiotics Pharmacokinetics and Efficacy6.1%
- Antimicrobial Resistance in Staphylococcus4.2%
- Pharmaceutical and Antibiotic Environmental Impacts3.8%
- Antibiotic Use and Resistance3.5%
- Bacterial Identification and Susceptibility Testing3.2%
- その他63.4%
共著者
- George A. Jacoby24
- J S Wolfson16
- Erica S. Shenoy14
- Q. C. Truong-Bolduc10
- Ari Robicsek9
- Jacob Strahilevitz8
- Chi Hye Park7
- E Y Ng6
- Morton N. Swartz6
- Tianhong Dai6
- Chanu Rhee5
- Kimon C. Zachary5
- Minggui Wang5
- Bénédicte Fournier4
- Gail McHugh4
- Jacob E. Lazarus4
- Jacob E. Lemieux4
- Mary Jane Ferraro4
- Melis N. Anahtar4
- Michael Klompas4
- Michele Trucksis4
- Minghua Wang4
- Sinéad B. Chapman4
- Adrianne Gladden-Young3
全論文
- Raman Techniques: Fundamentals and Frontiers
著者: Robin R. Jones, David C. Hooper, Liwu Zhang, D. Wolverson, Ventsislav K. Valev - Nanoscale Research Letters 2019 被引用: 777
- Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents
著者: Sameer S. Kadri, Jennifer Adjemian, Yi Ling Lai, Alicen B. Spaulding, Emily Ricotta, D. Rebecca Prevots, Tara N. Palmore, Chanu Rhee, Michael Klompas, John P. Dekker, John H. Powers, Anthony F. Suffredini, David C. Hooper, Scott K. Fridkin, Robert L. Danner - Clinical Infectious Diseases 2018 被引用: 567
- Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
著者: David C. Hooper, George A. Jacoby - Cold Spring Harbor Perspectives in Medicine 2016 被引用: 533
- Mechanisms of drug resistance: quinolone resistance
著者: David C. Hooper, George A. Jacoby - Annals of the New York Academy of Sciences 2015 被引用: 683
- Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline
著者: Sara E. Boyd, David M. Livermore, David C. Hooper, William Hope - Antimicrobial Agents and Chemotherapy 2020 被引用: 291
- Hospital-Acquired Infections Due to Gram-Negative Bacteria
著者: Anton Y. Peleg, David C. Hooper - New England Journal of Medicine 2010 被引用: 1,510
- A decision algorithm to promote outpatient antimicrobial stewardship for uncomplicated urinary tract infection
著者: Sanjat Kanjilal, Michael Oberst, Sooraj Boominathan, Helen Zhou, David C. Hooper, David Sontag - Science Translational Medicine 2020 被引用: 92
- Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals
著者: Sameer S. Kadri, Yi Ling Lai, Sarah Warner, Jeffrey R. Strich, Ahmed Babiker, Emily Ricotta, Cumhur Y. Demirkale, John P. Dekker, Tara N. Palmore, Chanu Rhee, Michael Klompas, David C. Hooper, John H. Powers, Arjun Srinivasan, Robert L. Danner, Jennifer Adjemian - The Lancet Infectious Diseases 2020 被引用: 270
- Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
著者: Ari Robicsek, Jacob Strahilevitz, George A. Jacoby, Mark J. Macielag, Darren Abbanat, Chi Hye Park, Karen Bush, David C. Hooper - Nature Medicine 2005 被引用: 1,023
- Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
著者: Jacob Strahilevitz, George A. Jacoby, David C. Hooper, Ari Robicsek - Clinical Microbiology Reviews 2009 被引用: 924
- Plasmid-Mediated Quinolone Resistance
著者: George A. Jacoby, Jacob Strahilevitz, David C. Hooper - Microbiology Spectrum 2014 被引用: 463
- Antimicrobial blue light inactivation of pathogenic microbes: State of the art
著者: Yucheng Wang, Ying Wang, Yuguang Wang, Clinton K. Murray, Michael R. Hamblin, David C. Hooper, Tianhong Dai - Drug Resistance Updates 2017 被引用: 292
- Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones
著者: David C. Hooper - Clinical Infectious Diseases 2001 被引用: 507
- Emerging Mechanisms of Fluoroquinolone Resistance
著者: David C. Hooper - Emerging infectious diseases 2001 被引用: 607
- The worldwide emergence of plasmid-mediated quinolone resistance
著者: Ari Robicsek, George A. Jacoby, David C. Hooper - The Lancet Infectious Diseases 2006 被引用: 972
- Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
著者: Joseph W. Chow, Michael J. Fine, David M. Shlaes, John P. Quinn, David C. Hooper, Michaekl P. Johnson, Reuben Ramphal, Marilyn M. Wagener, D Miyashiro, Victor L. Yu - Annals of Internal Medicine 1991 被引用: 895
- Genes Contributing to Staphylococcus aureus Fitness in Abscess- and Infection-Related Ecologies
著者: Michael D. Valentino, Lucy Foulston, Ama Sadaka, Veronica N. Kos, Régis Villet, John P. Santa Maria, David W. Lazinski, Andrew Camilli, Suzanne Walker, David C. Hooper, Michael S. Gilmore - mBio 2014 被引用: 156
- Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
著者: David C. Hooper - Clinical Infectious Diseases 2000 被引用: 399
- Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score–Matched Analysis From 130 US Hospitals
著者: Sameer S. Kadri, Bruce Swihart, Stephanie Bonne, Samuel F. Hohmann, Laura Hennessy, Peter Louras, Heather L. Evans, Chanu Rhee, Anthony F. Suffredini, David C. Hooper, Dean Follmann, Eileen M. Bulger, Robert L. Danner - Clinical Infectious Diseases 2016 被引用: 121
- Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme
著者: Chi Hye Park, Ari Robicsek, George A. Jacoby, Daniel F. Sahm, David C. Hooper - Antimicrobial Agents and Chemotherapy 2006 被引用: 750
- MgrA Is a Multiple Regulator of Two New Efflux Pumps inStaphylococcus aureus
著者: Q. C. Truong-Bolduc, Paul M. Dunman, Jacob Strahilevitz, Steven J. Projan, David C. Hooper - Journal of Bacteriology 2005 被引用: 294
- Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks
著者: Gustavo Cerqueira, Ashlee M. Earl, Christoph M. Ernst, Yonatan H. Grad, John P. Dekker, Michael Feldgarden, Sinéad B. Chapman, João Luís Reis-Cunha, Terrance Shea, Sarah Young, Qiandong Zeng, Mary L. Delaney, Diane Kim, Ellena M. Peterson, Thomas O’Brien, Mary Jane Ferraro, David C. Hooper, Susan S. Huang, James E. Kirby, Andrew B. Onderdonk, Susan J. Birren, Deborah T. Hung, Lisa A. Cosimi, Jennifer R. Wortman, Cheryl I. Murphy, William P. Hanage - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 被引用: 170
- New Plasmid-Mediated Quinolone Resistance Gene, qnrC , Found in a Clinical Isolate of Proteus mirabilis
著者: Minghua Wang, Qinglan Guo, Xiaogang Xu, Xiaoying Wang, Xinyu Ye, Shi Wu, David C. Hooper, Minggui Wang - Antimicrobial Agents and Chemotherapy 2009 被引用: 328
- oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae
著者: Hong Bin Kim, Minghua Wang, Chi Hye Park, Eui-Chong Kim, George A. Jacoby, David C. Hooper - Antimicrobial Agents and Chemotherapy 2009 被引用: 270
